2 terminated, 1 completed, 1 not yet recruiting. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 2, Completed 1, Not yet recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Acute Alcoholic Hepatitis: new trials by email Literature Review of Acute Alcoholic Hepatitis trials Research Report on Acute Alcoholic Hepatitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MRG-001 in Patients With Alcoholic Hepatitis MRG-001 - Alcoholic Hepatitis, Acute Alcoholic Hepatitis | Phase 2 | Not yet recruiting | MedRegen LLC | 32 | 2024-09-01 | 2024-03-13 |
| Digoxin In Treatment of Alcohol Associated Hepatitis Intravenous digoxin - Acute Alcoholic Hepatitis, Chemical and Drug Induced Liver Injury | Phase 2 | Terminated | Yale University | 23 | 2021-10-08 | 2026-09-29 |
| Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF IDN-6556, Placebo - Acute on Chronic Hepatic Failure, Acute Liver Failure | Phase 2 | Terminated | Conatus Pharmaceuticals Inc. | 23 | 2013-09-01 | 2016-04-11 |
| Efficacy Study of Anakinra, Pentoxifylline, and Zinc Compared to Methylprednisolone in Severe Acute Alcoholic Hepatitis Anakinra, Pentoxifylline, Zinc Sulfate - Acute Alcoholic Hepatitis | Phase 2 / Phase 3 | Completed | Mack Mitchell | 104 | 2013-09-01 | 2021-11-01 |
Hepatitis, Alcoholic (3) · Alcohol-Induced Disorders (1) · Chemical and Drug Induced Liver Injury (1) · Fatty Liver, Alcoholic (1) · Fibrosis (1) · Hepatitis (1) · Infections (1) · Liver Cirrhosis (1) · Liver Diseases (1) · Liver Diseases, Alcoholic (1) · Liver Failure (1) · Liver Failure, Acute (1)
Alcohol-Related Disorders (4) · Chemically-Induced Disorders (4) · Digestive System Diseases (4) · Substance-Related Disorders (4) · Alcohol-Induced Disorders (3) · Hepatitis (3) · Liver Diseases (3) · Liver Diseases, Alcoholic (3) · Drug-Related Side Effects and Adverse Reactions (1) · Fatty Liver (1) · Hepatic Insufficiency (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Poisoning (1)
3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid (1) · Digoxin (1) · Drugs, Generic (1) · Interleukin 1 Receptor Antagonist Protein (1) · Methylprednisolone (1) · Pentoxifylline (1) · Zinc Sulfate (1)
Conatus Pharmaceuticals Inc. (1) · Mack Mitchell (1) · MedRegen LLC (1) · Yale University (1)
United States (3) · United Kingdom (1)
Ali R Ahmadi, MD PhD (1) · Arthur J McCullough, MD (1) · Bubu Banini, MD, PhD (1) · Craig J McClain, MD (1) · Gyongi Szabo, MD (1) · Mack C Mitchell, MD (1) · Stephen Ryder, Dr. (1)
PMID 31811953, PMID 35084335, PMID 35340032, PMID 37011138, PMID 37633275
U01AA021893 (1)